Baltimore, MD (3/22/2023) — BC3 Technologies, a privately held medical device company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SEAL Hemostatic ...
BC3 Technologies has received a U.S. patent that protects its proprietary material, chemistry, technology, and method of its product SEAL Hemostatic Wound Spray for rapid and efficient management of ...
THE investigation into BC3 Racing is the "biggest undertaken by the sport's principal authority". The investigation must be completed - hopefully soon - before Racing Victoria stewards or the Racing ...
BACKGROUNDS OKAY. IN THIS MORNING’S MEDICAL ALERT, A BALTIMORE BASED COMPANY HAS JUST RECEIVED A PATENT FOR NEW WOUND SPRAY AIMED AT STOPPING SEVERE BLEEDING VERY QUICKLY. JOINING US LIVE THIS MORNING ...
So amid racing's dreamers and schemers the arrival of the ex-shrink with an unusual strategy to break in to the local market with a risky game plan - and whispers he ran a mysterious but wildly ...
BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 Technologies, a Baltimore-based, minority-owned company revolutionizing emergency medical response and trauma care, has received a U.S. patent that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results